LAWRENCE, Mass., Dec. 16, 2010 /PRNewswire/ — NxStage Medical,
Inc. (Nasdaq:
NXTM), a leading manufacturer of innovative dialysis products,
today announced that a group of its first patients are celebrating
their seven-year anniversary of home hemodialysis treatment with
the NxStage® System One™, the only hemodialysis machine
cleared by the FDA for home use. Each of these patients continues
to experience the improved health and quality of life benefits
possible with more frequent home hemodialysis using the System
One.
As early adopters of daily home hemodialysis with the NxStage
System One, each of the patients arrived at the decision to try
NxStage at various stages in his treatment for end stage renal
disease (ESRD). These patients–Craig, Carl, and Everette–began
treatment with the NxStage System One in December, 2003 as part of
NxStage’s groundbreaking clinical trial for its home
indication.
Everette had been undergoing in-center dialysis treatments
when he learned about daily home hemodialysis with NxStage. “For
the past seven years, the NxStage System One has given me the
freedom to live my life closer to the way I want to live it and
allowed me to dedicate more time to my hobbies and business
dreams,” he said. “Thanks in part to NxStage and dialyzing
more frequently, I feel more healthy and active. I’ve come off
several blood pressure medications and play basketball twice a week
while spearheading my online clothing store.”
“This is a tremendous milestone not only for these patients, but
also for all of our patients, prescribing nephrologists, partners
and employees,” stated Jeffrey H. Burbank, founder and CEO of
NxStage Medical, Inc. “We are extremely gratified to see these
patients thriving and are excited to expand access to the life
changing benefits possible with more frequent home hemodialysis
using the System One to a gro
‘/>”/>
